Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2026-02-17 4:33 pm Purchase | 2025-12-31 | 13G | eHealth, Inc. EHTH | Palo Alto Investors LP | 1,531,429 4.900% | 1,531,429 (New Position) | Filing History |
| 2025-02-13 4:02 pm Purchase | 2024-09-30 | 13G | Revance Therapeutics, Inc. RVNC | Palo Alto Investors LP | 1,611,787 1.540% | 1,611,787 (New Position) | Filing History |
| 2024-02-14 4:55 pm Unchanged | 2024-02-14 | 13G | Revance Therapeutics, Inc. RVNC | Palo Alto Investors LP | 0 0.000% | 0 (Unchanged) | Filing |
| 2024-02-14 4:54 pm Unchanged | 2024-02-14 | 13G | eHealth, Inc. EHTH | Palo Alto Investors LP | 0 0.000% | 0 (Unchanged) | Filing |
| 2024-02-14 4:52 pm Unchanged | 2024-02-14 | 13G | Karyopharm Therapeutics Inc. KPTI | Palo Alto Investors LP | 0 0.000% | 0 (Unchanged) | Filing |
| 2023-04-03 2:24 pm Unchanged | 2023-04-03 | 13G | Alimera Sciences, Inc. ALIM | Palo Alto Investors LP | 0 0.000% | 0 (Unchanged) | Filing |
| 2023-02-14 4:23 pm Unchanged | 2023-02-14 | 13G | Vanda Pharmaceuticals Inc. VNDA | Palo Alto Investors LP | 0 0.000% | 0 (Unchanged) | Filing |
| 2023-02-14 4:22 pm Unchanged | 2023-02-14 | 13G | Revance Therapeutics, Inc. RVNC | Palo Alto Investors LP | 0 0.000% | 0 (Unchanged) | Filing |
| 2023-02-14 4:21 pm Unchanged | 2023-02-14 | 13G | Karyopharm Therapeutics Inc. KPTI | Palo Alto Investors LP | 0 0.000% | 0 (Unchanged) | Filing |
| 2023-02-14 4:19 pm Unchanged | 2023-02-14 | 13G | Insmed Incorporated INSM | Palo Alto Investors LP | 0 0.000% | 0 (Unchanged) | Filing |
| 2023-02-14 4:18 pm Unchanged | 2023-02-14 | 13G | Epizyme, Inc. EPZM | Palo Alto Investors LP | 0 0.000% | 0 (Unchanged) | Filing |
| 2023-02-14 4:17 pm Unchanged | 2023-02-14 | 13G | eHealth, Inc. EHTH | Palo Alto Investors LP | 0 0.000% | 0 (Unchanged) | Filing |
| 2023-02-14 4:12 pm Unchanged | 2023-02-14 | 13G | Alimera Sciences, Inc. ALIM | Palo Alto Investors LP | 0 0.000% | 0 (Unchanged) | Filing |
| 2022-02-14 5:11 pm Unchanged | 2022-02-14 | 13G | Epizyme, Inc. EPZM | Palo Alto Investors LP | 0 0.000% | 0 (Unchanged) | Filing |
| 2022-02-14 5:09 pm Unchanged | 2022-02-14 | 13G | Karyopharm Therapeutics Inc. KPTI | Palo Alto Investors LP | 0 0.000% | 0 (Unchanged) | Filing |
| 2022-02-14 5:08 pm Unchanged | 2022-02-14 | 13G | Vanda Pharmaceuticals Inc. VNDA | Palo Alto Investors LP | 0 0.000% | 0 (Unchanged) | Filing |
| 2022-02-14 5:07 pm Unchanged | 2022-02-14 | 13G | Alimera Sciences, Inc. ALIM | Palo Alto Investors LP | 0 0.000% | 0 (Unchanged) | Filing |
| 2022-02-14 5:04 pm Unchanged | 2022-02-14 | 13G | Revance Therapeutics, Inc. RVNC | Palo Alto Investors LP | 0 0.000% | 0 (Unchanged) | Filing |
| 2022-02-14 5:03 pm Unchanged | 2022-02-14 | 13G | STAAR Surgical Company STAA | Palo Alto Investors LP | 0 0.000% | 0 (Unchanged) | Filing |
| 2022-02-14 5:01 pm Unchanged | 2022-02-14 | 13G | Insmed Incorporated INSM | Palo Alto Investors LP | 0 0.000% | 0 (Unchanged) | Filing |